Remdesivir lowered risk of death among hospitalized COVID patients by 54% --study

Primary tabs

posted by mike kraft on Wed, 2024-06-26 19:01
Remdesivir tied to 54% lower risk of death among hospitalized COVID patients A comparison study based on two large, open-label studies links the antiviral drug remdesivir (Veklury) to a 54% lower risk of all-cause death and shorter hospital stays compared with standard of care (SOC) alone in hospitalized COVID-19 patients requiring supplemental oxygen in 2020.  CIDRAP

...

In the United States, remdesivir is recommended for hospitalized COVID-19 patients and those with mild or moderate illness at high risk of severe disease within 7 days of symptom onset.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Groups this Group Post belongs to: 
- Private group -
howdy folks

User login

What is the weather on the sun

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Who's online

There are currently 0 users online.

Facebook  Twitter  RSS